ADMAADMA BIOLOGICS, INC.vs its industry peers
A metric-by-metric comparison of ADMA BIOLOGICS, INC. against SIC 2836 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ADMAEsta | $1.9B#8 | 12.3x#1 | 4.7x#10 | 3.8x#3 | 19.6%#7 | -25.7%#9 | 37.5%#3 | 36.0%#1 | 32.9%#1 | 5#2 | -45.2%#14 | — |
| TARS | $3.4B#1 | — | 9.9x#12 | 7.6x#5 | 146.7%#2 | 43.1%#5 | -15.7%#5 | -19.0%#5 | -33.0%#3 | — | 54.4%#7 | — |
| DNLI | $3.3B#2 | — | 3.9x#7 | — | — | -21.2%#7 | — | -61.4%#11 | — | — | — | — |
| RVMDW | $2.8B#3 | — | 1.1x#1 | — | — | -88.5%#13 | — | -43.4%#8 | — | — | 4197.3%#1 | — |
| BEAM | $2.4B#4 | — | 2.3x#4 | 17.2x#7 | 120.0%#3 | 78.8%#3 | -274.6%#7 | -7.5%#4 | -40.5%#4 | — | 1.5%#12 | — |
| BCRX | $2.1B#5 | — | — | 2.4x#2 | 94.1%#4 | 396.9%#1 | 39.0%#2 | — | — | — | 5.4%#10 | — |
| KOD | $2.1B#6 | — | 34.0x#13 | — | — | -30.5%#10 | — | -376.4%#13 | — | — | 252.9%#3 | — |
| VCEL | $2.0B#7 | 82.8x#2 | 5.5x#11 | 7.4x#4 | 16.5%#9 | 59.4%#4 | 4.0%#4 | 4.5%#2 | 4.0%#2 | 7#1 | 19.6%#8 | — |
| COAG | $1.9B#9 | — | 4.1x#8 | — | — | — | — | 0.0%#3 | — | — | — | — |
| VIR | $1.8B#10 | — | 1.8x#2 | 25.8x#9 | -7.6%#10 | 16.1%#6 | -699.2%#8 | -44.6%#9 | — | — | 115.5%#5 | — |
| RXRX | $1.7B#11 | — | 1.9x#3 | 23.2x#8 | 26.9%#6 | -39.1%#12 | -867.9%#9 | -70.5%#12 | -175.2%#6 | — | -33.0%#13 | — |
| TSHA | $1.7B#12 | — | 4.3x#9 | 169.0x#10 | 17.3%#8 | -22.1%#8 | -1130.6%#10 | -28.1%#6 | — | — | 79.2%#6 | — |
| INBX | $1.6B#13 | — | — | 1205.0x#11 | 550.0%#1 | -108.3%#14 | -10386.5%#11 | — | — | — | 300.8%#2 | — |
| NVAX | $1.5B#14 | — | — | 1.4x#1 | 64.7%#5 | 334.8%#2 | 40.3%#1 | — | — | — | 8.1%#9 | — |
| MAZE | $1.3B#15 | — | 3.0x#5 | 8.0x#6 | — | -351.0%#15 | -85.3%#6 | -28.9%#7 | -49.4%#5 | — | 3.4%#11 | — |
| CGEM | $1.3B#16 | — | 3.2x#6 | — | -100.0%#11 | -31.2%#11 | — | -53.8%#10 | — | — | 226.4%#4 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2836). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. Esta tabla agotó el tiempo durante su construcción, por lo que cubre parte del grupo; los rangos son solo dentro de las filas mostradas y se completará en breve. Table built 2026-09-16.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice